Skip to main content
. 2023 Nov 21;8(4):1042–1050. doi: 10.1182/bloodadvances.2023011489

Table 2.

Outcomes and toxicities after axi-cel in the mITT cohort

Covariate Before PS matching
After PS matching
No BT, N = 132 BT, N=143 P value No BT, N = 97 BT, N = 97 P value
CRS grade ≥3 5% 8% .35 6% 7% >.99
CRES/ICANS grade ≥3 27% 34% .2 28% 32% .64
Need for G-CSF 33% 48% .01 32% 42% .18
ICU admission 23% 42% .001 25% 37% .09
Mean duration of hospital stay (d) 15.7 18.5 .04 16 18 .33

CRES, CAR-related encephalopathy syndrome.